Global Proteomics Market – Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery, Others), End User, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)
Executive Summary
The Global Proteomics Market is estimated at USD 3.49 Billion in the year 2020. Proteomics market growth is driven by rise in popularity of personalized medicines, surge in R&D expenditure, and technological advancements associated with proteomics components. Moreover, high costs associated with components and dearth of skilled professionals hamper the market growth. Conversely, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities for the proteomics market growth. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2026. However, the market is constrained by strict regulatory norms and the high cost of the instruments.
In the human body, proteins play an essential role in the biological activities and hence the measurement of its expression levels in healthy and diseased individuals should uncover novel scientific insights. Although proteomics markets has been in existence for more than 25 years with initially immunoassay and ELISA market and later mass spec technologies that help stabilize ions and currently the proteomics high-plex market that are in initial stages but expected to see major expansion. The growing prominence of nano proteomics, development of personalized proteomics for precision health, and the high growth opportunities in emerging countries are expected to offer potential growth opportunities to market players.
North America held the largest market share of nearly 50.32% of the total proteomics market in 2020, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. Growth is also attributed to the increasing investments in the development of structure-based drug design, growing research in the field of proteomics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.
Scope of the Report
The Global Proteomics Market is estimated at USD 3.49 Billion in the year 2020. Proteomics market growth is driven by rise in popularity of personalized medicines, surge in R&D expenditure, and technological advancements associated with proteomics components. Moreover, high costs associated with components and dearth of skilled professionals hamper the market growth. Conversely, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities for the proteomics market growth. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2026. However, the market is constrained by strict regulatory norms and the high cost of the instruments.
In the human body, proteins play an essential role in the biological activities and hence the measurement of its expression levels in healthy and diseased individuals should uncover novel scientific insights. Although proteomics markets has been in existence for more than 25 years with initially immunoassay and ELISA market and later mass spec technologies that help stabilize ions and currently the proteomics high-plex market that are in initial stages but expected to see major expansion. The growing prominence of nano proteomics, development of personalized proteomics for precision health, and the high growth opportunities in emerging countries are expected to offer potential growth opportunities to market players.
North America held the largest market share of nearly 50.32% of the total proteomics market in 2020, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. Growth is also attributed to the increasing investments in the development of structure-based drug design, growing research in the field of proteomics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is also supporting the growth of this market.
Scope of the Report
- The report presents the analysis of Proteomics market for the historical period 2016-2020 and forecast period of 2021-2026.
- The report analyses the Proteomics Market by value (USD Million).
- The report analyses the Proteomics Market by Component (Instruments, Reagents, Services).
- The report analyses the Proteomics Market by Application (Clinical Diagnostic, Drug Discovery, Others).
- The report analyses the Proteomics Market End User (Hospitals, Labs and Clinics, Others).
- The Global Proteomics Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA) By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India, South Korea).
- The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Component, By Application, By End User.
- Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck KGaA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher, QIAGEN, Agilent Tecnologies, Bruker Corporation, GE Healthcare, Eurofins Scientific, Wuxi APPTECC, Promega Corporation.
- Pharmaceutical and Healthcare Companies
- Biotechnology Companies
- Consulting and Advisory Firms
- Government and Policy Makers
- Regulatory Authorities
1. REPORT SCOPE AND METHODOLOGY
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. PROTEOMICS MARKET: PRODUCT OUTLOOK
4. GLOBAL PROTEOMICS MARKET: SIZING AND FORECAST
4.1 Global Proteomics Market Size, By Value, Year 2016-2026
5. GLOBAL PROTEOMICS MARKET SEGMENTATION - BY COMPONENT, BY APPLICATION, BY END USER
5.1 Competitive Scenario of Global Proteomics Market: By Component
5.1.1 Instruments ? Market Size and Forecast (2016-2026)
5.1.2 Reagents ? Market Size and Forecast (2016-2026)
5.1.3 Services ? Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Proteomics Market: By Application
5.2.1 Clinical Diagnostic ? Market Size and Forecast (2016-2026)
5.2.2 Drug Discovery ? Market Size and Forecast (2016-2026)
5.2.3 Others ? Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Proteomics Market: By End User
5.3.1 Hospitals ? Market Size and Forecast (2016-2026)
5.3.2 Labs and Clinics ? Market Size and Forecast (2016-2026)
5.3.3 Others ? Market Size and Forecast (2016-2026)
6.GLOBAL PROTEOMICS MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Proteomics Market : By Region
7. NORTH AMERICA PROTEOMICS MARKET: AN ANALYSIS (2016-2026)
7.1 North America Proteomics Market : Size and Forecast (2016-2026), By Value
7.2 North America Proteomics Market ? Prominent Companies
7.3 Market Segmentation By Component (Instruments, Reagents and Services)
7.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
7.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
7.6 North America Proteomics Market: Country Analysis
7.7 Market Opportunity Chart of North America Proteomics Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Proteomics Market: By Country
7.9 United States Proteomics Market: Size and Forecast (2016-2026), By Value
7.10 United States Proteomics Market Segmentation - By Component, By Application, By End User (2016-2026)
7.11 Canada Proteomics Market: Size and Forecast (2016-2026), By Value
7.12 Canada Proteomics Market Segmentation - By Component, By Application, By End User (2016-2026)
8. EUROPE PROTEOMICS MARKET: AN ANALYSIS (2016-2026)
8.1 Europe Proteomics Market : Size and Forecast (2016-2026), By Value
8.2 Europe Proteomics Market ? Prominent Companies
8.3 Market Segmentation By Component (Instruments, Reagents and Services)
8.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
8.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
8.6 Europe Proteomics Market: Country Analysis
8.7 Market Opportunity Chart of Europe Proteomics Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Proteomics Market: By Country
8.9 Germany Proteomics Market: Size and Forecast (2016-2026), By Value
8.10 Germany Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.11 United Kingdom Proteomics Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.13 France Proteomics Market: Size and Forecast (2016-2026), By Value
8.14 France Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.15 Italy Proteomics Market: Size and Forecast (2016-2026), By Value
8.16 Italy Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9. ASIA PACIFIC PROTEOMICS MARKET: AN ANALYSIS (2016-2026)
9.1 Asia Pacific Proteomics Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Proteomics Market ? Prominent Companies
9.3 Market Segmentation By Component (Instruments, Reagents and Services)
9.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
9.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
9.6 Asia Pacific Proteomics Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Proteomics Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Proteomics Market: By Country
9.9 China Proteomics Market: Size and Forecast (2016-2026), By Value
9.10 China Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.11 Japan Proteomics Market: Size and Forecast (2016-2026), By Value
9.12 Japan Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.13 India Proteomics Market: Size and Forecast (2016-2026), By Value
9.14 India Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.15 South Korea Proteomics Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
10. GLOBAL PROTEOMICS MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Proteomics Market - By Component, 2026
11.2 Market Attractiveness Chart of Global Proteomics Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Proteomics Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Proteomics Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. COMPANY ANALYSIS
13.1 Merck KGaA
13.2 Bio-Rad Laboratories Inc.
13.3 Thermo Fisher Scientific Inc.
13.4 Danaher
13.5 QIAGEN
13.6 Agilent Technologies
13.7 Bruker Corporation
13.8 GE Healthcare
13.9 Eurofins Scientific
13.10 Wuxi APPTECC
13.11 Promega Corporation
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
3. PROTEOMICS MARKET: PRODUCT OUTLOOK
4. GLOBAL PROTEOMICS MARKET: SIZING AND FORECAST
4.1 Global Proteomics Market Size, By Value, Year 2016-2026
5. GLOBAL PROTEOMICS MARKET SEGMENTATION - BY COMPONENT, BY APPLICATION, BY END USER
5.1 Competitive Scenario of Global Proteomics Market: By Component
5.1.1 Instruments ? Market Size and Forecast (2016-2026)
5.1.2 Reagents ? Market Size and Forecast (2016-2026)
5.1.3 Services ? Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Proteomics Market: By Application
5.2.1 Clinical Diagnostic ? Market Size and Forecast (2016-2026)
5.2.2 Drug Discovery ? Market Size and Forecast (2016-2026)
5.2.3 Others ? Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Proteomics Market: By End User
5.3.1 Hospitals ? Market Size and Forecast (2016-2026)
5.3.2 Labs and Clinics ? Market Size and Forecast (2016-2026)
5.3.3 Others ? Market Size and Forecast (2016-2026)
6.GLOBAL PROTEOMICS MARKET: REGIONAL ANALYSIS
6.1 Competitive Scenario of Global Proteomics Market : By Region
7. NORTH AMERICA PROTEOMICS MARKET: AN ANALYSIS (2016-2026)
7.1 North America Proteomics Market : Size and Forecast (2016-2026), By Value
7.2 North America Proteomics Market ? Prominent Companies
7.3 Market Segmentation By Component (Instruments, Reagents and Services)
7.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
7.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
7.6 North America Proteomics Market: Country Analysis
7.7 Market Opportunity Chart of North America Proteomics Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Proteomics Market: By Country
7.9 United States Proteomics Market: Size and Forecast (2016-2026), By Value
7.10 United States Proteomics Market Segmentation - By Component, By Application, By End User (2016-2026)
7.11 Canada Proteomics Market: Size and Forecast (2016-2026), By Value
7.12 Canada Proteomics Market Segmentation - By Component, By Application, By End User (2016-2026)
8. EUROPE PROTEOMICS MARKET: AN ANALYSIS (2016-2026)
8.1 Europe Proteomics Market : Size and Forecast (2016-2026), By Value
8.2 Europe Proteomics Market ? Prominent Companies
8.3 Market Segmentation By Component (Instruments, Reagents and Services)
8.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
8.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
8.6 Europe Proteomics Market: Country Analysis
8.7 Market Opportunity Chart of Europe Proteomics Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Proteomics Market: By Country
8.9 Germany Proteomics Market: Size and Forecast (2016-2026), By Value
8.10 Germany Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.11 United Kingdom Proteomics Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.13 France Proteomics Market: Size and Forecast (2016-2026), By Value
8.14 France Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
8.15 Italy Proteomics Market: Size and Forecast (2016-2026), By Value
8.16 Italy Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9. ASIA PACIFIC PROTEOMICS MARKET: AN ANALYSIS (2016-2026)
9.1 Asia Pacific Proteomics Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Proteomics Market ? Prominent Companies
9.3 Market Segmentation By Component (Instruments, Reagents and Services)
9.4 Market Segmentation By Application (Clinical Diagnostic, Drug Discovery and Others)
9.5 Market Segmentation By End User (Hospitals, Labs and Clinics, Others)
9.6 Asia Pacific Proteomics Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Proteomics Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Proteomics Market: By Country
9.9 China Proteomics Market: Size and Forecast (2016-2026), By Value
9.10 China Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.11 Japan Proteomics Market: Size and Forecast (2016-2026), By Value
9.12 Japan Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.13 India Proteomics Market: Size and Forecast (2016-2026), By Value
9.14 India Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
9.15 South Korea Proteomics Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Proteomics Market Segmentation - By Component, By Application, and By End User (2016-2026)
10. GLOBAL PROTEOMICS MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Trends
11. MARKET ATTRACTIVENESS
11.1 Market Attractiveness Chart of Global Proteomics Market - By Component, 2026
11.2 Market Attractiveness Chart of Global Proteomics Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Proteomics Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Proteomics Market - By Region, 2026
12. COMPETITIVE LANDSCAPE
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. COMPANY ANALYSIS
13.1 Merck KGaA
13.2 Bio-Rad Laboratories Inc.
13.3 Thermo Fisher Scientific Inc.
13.4 Danaher
13.5 QIAGEN
13.6 Agilent Technologies
13.7 Bruker Corporation
13.8 GE Healthcare
13.9 Eurofins Scientific
13.10 Wuxi APPTECC
13.11 Promega Corporation
TABLES AND FIGURES
Figure 1: Global Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Expenses (% GDP), 2015-2019
Figure 6: GDP per Capita Growth (annual %)
Figure 7: World Population 65 Years & Above (% of Total), 2015-2019
Figure 8: Global Proteomics Market- By Component Market Share, 2020 & 2026
Figure 9: Global Proteomics Market- By Instruments, By Value (USD Million), 2016-2026
Figure 10: Global Proteomics Market- By Reagents, By Value (USD Million), 2016-2026
Figure 11: Global Proteomics Market- By Services, By Value (USD Million), 2016-2026
Figure 12: Global Proteomics Market- By Application Market Share, 2020 & 2026
Figure 13: Global Proteomics Market- By Clinical Diagnostic, By Value (USD Million), 2016-2026
Figure 14: Global Proteomics Market- By Drug Discovery, By Value (USD Million), 2016-2026
Figure 15: Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
Figure 16: Global Proteomics Market- By End User Market Share, 2020 & 2026
Figure 17: Global Proteomics Market- By Hospitals, By Value (USD Million), 2016-2026
Figure 18: Global Proteomics Market- By Labs and Clinics, By Value (USD Million), 2016-2026
Figure 19: Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
Figure 20: Global Proteomics Market- By Region Market Share, 2020 & 2026
Figure 21: North America Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 22: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 23: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 24: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 25: North America Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 26: North America Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 27: North America Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 28: Market Opportunity Chart of North America Proteomics Market- By Country, By Value (Year-2026)
Figure 29: North America Proteomics Market- By Country Market Share, 2020 & 2026
Figure 30: United States Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 31: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 32: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 33: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 34: United State Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 35: United State Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 36: United State Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 37: Canada Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 38: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 39: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 40: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 41: Canada Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 42: Canada Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 43: Canada Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 44: Europe Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 45: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 46: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 47: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 48: Europe Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 49: Europe Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 50: Europe Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 51: Market Opportunity Chart of Europe Proteomics Market- By Country, By Value (Year-2026)
Figure 52: Europe Proteomics Market- By Country Market Share, 2020 & 2026
Figure 53: Germany Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 54: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 55: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 56: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 57: Germany Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 58: Germany Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 59: Germany Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 60: United Kingdom Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 61: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 62: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 63: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 64: United Kingdom Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 65: United Kingdom Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 66: United Kingdom Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 67: France Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 68: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 69: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 70: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 71: France Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 72: France Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 73: France Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 74: Italy Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 75: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 76: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 77: Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 78: Italy Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 79: Italy Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 80: Italy Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 81: Asia Pacific Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 82: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 83: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 84: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 85: Asia Pacific Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 86: Asia Pacific Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 87: Asia Pacific Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 88: Market Opportunity Chart of APAC Proteomics Market- By Country, By Value (Year-2026)
Figure 89: APAC Proteomics Market- By Country Market Share, 2020 & 2026
Figure 90: China Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 91: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 92: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 93: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 94: China Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 95: China Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 96: China Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 97: Japan Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 98: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 99: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 100: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 101: Japan Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 102: Japan Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 103: Japan Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 104: India Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 105: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 106: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 107: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 108: India Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 109: India Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 110: India Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 111: India Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 112: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 113: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 114: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 115: South Korea Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 116: South Korea Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 117: South Korea Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 118: Market Attractiveness Chart of Global Proteomics Market- By Component (Year-2026)
Figure 119: Market Attractiveness Chart of Global Proteomics Market- By Application (Year-2026)
Figure 120: Market Attractiveness Chart of Global Proteomics Market- By End User (Year-2026)
Figure 121: Market Attractiveness Chart of Global Proteomics Market- By Region (Year-2026)
Figure 122: Global Proteomics company market share (%), 2020
Figure 123: Merck KGaA Sales Revenues, 2016-2020 (USD Million)
Figure 124: Merck KGaA Gross Profit, 2016-2020 (USD Million)
Figure 125: Merck KGaA Plc Sales Revenue Split, By Business Segment (%), FY2020
Figure 126: Merck KGaA Plc Sales Revenue Split, By Geography Segment (%), FY2020
Figure 127: Bio-Rad Laboratories Inc. Sales Revenues, 2015-2019 (USD Million)
Figure 128:Bio-Rad Laboratories Inc. Net Income, 2015-2019 (USD Million)
Figure 129: Bio-Rad Laboratories Inc. sales Revenues, By Business Segment (%), FY2019
Figure 130: Bio-Rad Laboratories Inc. sales Revenue, By Geographical Segment (%), FY2019
Figure 131: Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 132: Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
Figure 133: Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
Figure 134: Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 135: Danaher Sales Revenues, 2016-2020 (USD Million)
Figure 136: Danaher Gross Profit, 2016-2020 (USD Million)
Figure 137: Danaher sales Revenues, By Business Segment (%), FY2020
Figure 138: Danaher sales Revenue, By Geographical Segment (%), FY2020
Figure 139: QIAGEN Sales Revenues, 2016-2020 (USD Million)
Figure 140: QIAGEN Gross Profit, 2016-2020 (USD Million)
Figure 141: QIAGEN sales Revenues, By Business Segment (%), FY2020
Figure 142: QIAGEN sales Revenue, By Geographical Segment (%), FY2020
Figure 143: Agilent Technologies Sales Revenues, 2016-2020 (USD Million)
Figure 144: Agilent Technologies Net Income, 2016-2020 (USD Million)
Figure 145: Agilent Technologies sales Revenues, By Business Segment (%), FY2020
Figure 146: Agilent Technologies sales Revenue, By Geographical Segment (%), FY2020
Figure 147: Bruker Corporation Sales Revenues, 2016-2020 (USD Million)
Figure 148: Bruker Corporation Gross Profit, 2016-2020 (USD Million)
Figure 149: Bruker Corporation sales Revenues, By Business Segment (%), FY2020
Figure 150: Bruker Corporation sales Revenue, By Geographical Segment (%), FY2020
Figure 151: GE Healthcare Sales Revenues, 2016-2020 (USD Million)
Figure 152: GE Healthcare sales Revenues, By Business Segment (%), FY2020
Figure 153: GE Healthcare sales Revenue, By Geographical Segment (%), FY2020
Figure 154: Eurofins Scientific Sales Revenues, 2016-2020 (USD Million)
Figure 155: Eurofins Scientific sales Revenue, By Geographical Segment (%), FY2020
Figure 156: Wuxi APPTECC Revenue, 2015-2019 (In USD Million)
Figure 157: Wuxi APPTECC Net Sales, By Operating Segment, 2019 (In %)
Figure 1: Global Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Expenses (% GDP), 2015-2019
Figure 6: GDP per Capita Growth (annual %)
Figure 7: World Population 65 Years & Above (% of Total), 2015-2019
Figure 8: Global Proteomics Market- By Component Market Share, 2020 & 2026
Figure 9: Global Proteomics Market- By Instruments, By Value (USD Million), 2016-2026
Figure 10: Global Proteomics Market- By Reagents, By Value (USD Million), 2016-2026
Figure 11: Global Proteomics Market- By Services, By Value (USD Million), 2016-2026
Figure 12: Global Proteomics Market- By Application Market Share, 2020 & 2026
Figure 13: Global Proteomics Market- By Clinical Diagnostic, By Value (USD Million), 2016-2026
Figure 14: Global Proteomics Market- By Drug Discovery, By Value (USD Million), 2016-2026
Figure 15: Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
Figure 16: Global Proteomics Market- By End User Market Share, 2020 & 2026
Figure 17: Global Proteomics Market- By Hospitals, By Value (USD Million), 2016-2026
Figure 18: Global Proteomics Market- By Labs and Clinics, By Value (USD Million), 2016-2026
Figure 19: Global Proteomics Market- By Others, By Value (USD Million), 2016-2026
Figure 20: Global Proteomics Market- By Region Market Share, 2020 & 2026
Figure 21: North America Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 22: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 23: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 24: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 25: North America Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 26: North America Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 27: North America Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 28: Market Opportunity Chart of North America Proteomics Market- By Country, By Value (Year-2026)
Figure 29: North America Proteomics Market- By Country Market Share, 2020 & 2026
Figure 30: United States Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 31: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 32: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 33: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 34: United State Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 35: United State Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 36: United State Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 37: Canada Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 38: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 39: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 40: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 41: Canada Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 42: Canada Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 43: Canada Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 44: Europe Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 45: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 46: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 47: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 48: Europe Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 49: Europe Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 50: Europe Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 51: Market Opportunity Chart of Europe Proteomics Market- By Country, By Value (Year-2026)
Figure 52: Europe Proteomics Market- By Country Market Share, 2020 & 2026
Figure 53: Germany Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 54: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 55: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 56: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 57: Germany Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 58: Germany Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 59: Germany Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 60: United Kingdom Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 61: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 62: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 63: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 64: United Kingdom Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 65: United Kingdom Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 66: United Kingdom Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 67: France Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 68: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 69: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 70: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 71: France Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 72: France Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 73: France Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 74: Italy Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 75: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 76: Italy Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 77: Italy Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 78: Italy Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 79: Italy Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 80: Italy Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 81: Asia Pacific Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 82: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 83: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 84: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 85: Asia Pacific Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 86: Asia Pacific Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 87: Asia Pacific Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 88: Market Opportunity Chart of APAC Proteomics Market- By Country, By Value (Year-2026)
Figure 89: APAC Proteomics Market- By Country Market Share, 2020 & 2026
Figure 90: China Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 91: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 92: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 93: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 94: China Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 95: China Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 96: China Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 97: Japan Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 98: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 99: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 100: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 101: Japan Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 102: Japan Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 103: Japan Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 104: India Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 105: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 106: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 107: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 108: India Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 109: India Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 110: India Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 111: India Proteomics Market Size, By Value, 2016-2026 (USD Million)
Figure 112: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 113: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 114: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 115: South Korea Proteomics Market- By Component, By Value (USD Million), 2016-2026
Figure 116: South Korea Proteomics Market- By Application, By Value (USD Million), 2016-2026
Figure 117: South Korea Proteomics Market- By End User, By Value (USD Million), 2016-2026
Figure 118: Market Attractiveness Chart of Global Proteomics Market- By Component (Year-2026)
Figure 119: Market Attractiveness Chart of Global Proteomics Market- By Application (Year-2026)
Figure 120: Market Attractiveness Chart of Global Proteomics Market- By End User (Year-2026)
Figure 121: Market Attractiveness Chart of Global Proteomics Market- By Region (Year-2026)
Figure 122: Global Proteomics company market share (%), 2020
Figure 123: Merck KGaA Sales Revenues, 2016-2020 (USD Million)
Figure 124: Merck KGaA Gross Profit, 2016-2020 (USD Million)
Figure 125: Merck KGaA Plc Sales Revenue Split, By Business Segment (%), FY2020
Figure 126: Merck KGaA Plc Sales Revenue Split, By Geography Segment (%), FY2020
Figure 127: Bio-Rad Laboratories Inc. Sales Revenues, 2015-2019 (USD Million)
Figure 128:Bio-Rad Laboratories Inc. Net Income, 2015-2019 (USD Million)
Figure 129: Bio-Rad Laboratories Inc. sales Revenues, By Business Segment (%), FY2019
Figure 130: Bio-Rad Laboratories Inc. sales Revenue, By Geographical Segment (%), FY2019
Figure 131: Thermo Fisher Scientific Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 132: Thermo Fisher Scientific Inc. Net Income, 2016-2020 (USD Million)
Figure 133: Thermo Fisher Scientific Inc. sales Revenues, By Business Segment (%), FY2020
Figure 134: Thermo Fisher Scientific Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 135: Danaher Sales Revenues, 2016-2020 (USD Million)
Figure 136: Danaher Gross Profit, 2016-2020 (USD Million)
Figure 137: Danaher sales Revenues, By Business Segment (%), FY2020
Figure 138: Danaher sales Revenue, By Geographical Segment (%), FY2020
Figure 139: QIAGEN Sales Revenues, 2016-2020 (USD Million)
Figure 140: QIAGEN Gross Profit, 2016-2020 (USD Million)
Figure 141: QIAGEN sales Revenues, By Business Segment (%), FY2020
Figure 142: QIAGEN sales Revenue, By Geographical Segment (%), FY2020
Figure 143: Agilent Technologies Sales Revenues, 2016-2020 (USD Million)
Figure 144: Agilent Technologies Net Income, 2016-2020 (USD Million)
Figure 145: Agilent Technologies sales Revenues, By Business Segment (%), FY2020
Figure 146: Agilent Technologies sales Revenue, By Geographical Segment (%), FY2020
Figure 147: Bruker Corporation Sales Revenues, 2016-2020 (USD Million)
Figure 148: Bruker Corporation Gross Profit, 2016-2020 (USD Million)
Figure 149: Bruker Corporation sales Revenues, By Business Segment (%), FY2020
Figure 150: Bruker Corporation sales Revenue, By Geographical Segment (%), FY2020
Figure 151: GE Healthcare Sales Revenues, 2016-2020 (USD Million)
Figure 152: GE Healthcare sales Revenues, By Business Segment (%), FY2020
Figure 153: GE Healthcare sales Revenue, By Geographical Segment (%), FY2020
Figure 154: Eurofins Scientific Sales Revenues, 2016-2020 (USD Million)
Figure 155: Eurofins Scientific sales Revenue, By Geographical Segment (%), FY2020
Figure 156: Wuxi APPTECC Revenue, 2015-2019 (In USD Million)
Figure 157: Wuxi APPTECC Net Sales, By Operating Segment, 2019 (In %)
